We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

European Court Sides With Glaxo In Dual Pricing Case

Law360 (September 27, 2006, 12:00 AM EDT) -- Drug giant GlaxoSmithKline won a big victory Wednesday when the European Court of First Instance decided that a European Commission was wrong when it said the company’s subsidiary company couldn’t charge different prices for drugs sold in Spain and those intended for export.

Big drug companies have long argued that their market is different than others in Europe because national insurance programs set their prices.

The court agreed, saying that member states determine prices and thus, it cannot be presumed that parallel trade tends to reduce...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.